Chiari畸形1型合并脊髓空洞症手术预后分析

doi:10.3969/j.issn.1672-6731.2021.07.009

摘要/Abstract

摘要：

目的筛查Chiari畸形1型（CM1）合并脊髓空洞症患者行颅后窝减压术联合硬膜成形术后预后不良的危险因素。方法纳入2013年1月至2020年6月在武汉大学中南医院行颅后窝减压术联合硬膜成形术的47例CM1型合并脊髓空洞症患者，术后6个月采用传统评价标准和芝加哥Chiari畸形预后量表（CCOS）评价手术疗效，单因素和多因素Logistic回归分析筛查颅后窝减压术联合硬膜成形术后预后不良的相关危险因素。结果 47例患者根据CCOS评分分为治愈组（21例，CCOS评分为13~16）和未治愈组（26例，CCOS评分为4~12），未治愈组患者病程长于（t=4.709，P=0.000）、脊髓空洞宽度大于（t=3.074，P=0.004）治愈组。多因素Logistic回归分析显示，仅病程≥ 36个月是颅后窝减压术联合硬膜成形术后预后不良的危险因素（OR=21.948，95% CI：3.850~125.117；P=0.001）。结论病程≥ 36个月是CM1型合并脊髓空洞症患者颅后窝减压术联合硬膜成形术预后不良的危险因素，建议有明显症状的CM1型合并脊髓空洞症患者尽早手术治疗。

关键词: Arnold-Chiari畸形, 脊髓空洞症, 神经外科手术, 预后, 危险因素, Logistic模型

Abstract:

Objective To investigate the risk factors for poor prognosis of patients with Chiari malformation type 1 (CM1) complicated with syringomyelia treated by posterior fossa decompression with duraplasty (PFDD). Methods Forty-seven patients with CM1 complicated with syringomyelia who underwent PFDD at Zhongnan Hospital of Wuhan University from January 2013 to June 2020 were included. The prognosis was evaluated by the traditional evaluation criteria and Chicago Chiari Outcome Scale (CCOS) at 6 months postoperatively, and univariate and multivariate stepwise Logistic regression analyses were performed to screen for risk factors associated with poor outcome. Results Based on whether the CCOS score was greater than 12, 47 patients were divided into the cured group (n=21) and uncured group (n=26). Patients in the uncured group had longer disease duration (t=4.709, P=0.000) and greater syringomyelia width (t=3.074, P=0.004) than the cured group. Multivariable Logistic regression analysis showed that the long duration of disease (≥ 36 months) was an independent risk factor for poor surgical prognosis of patients after PFDD (OR=21.948, 95%CI:3.850-125.117; P=0.001). Conclusions Long duration of disease is an independent risk factor for poor surgical prognosis in patients with CM1 complicated with syringomyelia treated by PFDD, and early surgical treatment is recommended for the patients with symptomatic CM1 complicated with syringomyelia.

Key words: Arnold-Chiari malformation, Syringomyelia, Neurosurgical procedures, Prognosis, Risk factors, Logistic models

蔡远坤, 李帼, 刘征, 刘暌. Chiari畸形1型合并脊髓空洞症手术预后分析[J]. 中国现代神经疾病杂志, 2021, 21(7): 581-585.

CAI Yuan-kun, LI Guo, LIU Zheng, LIU Kui. Prognostic analysis of surgical treatment of Chiari malformation type 1 complicated with syringomyelia[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(7): 581-585.

https://journal11.magtechjournal.com/cjcnn/CN/Y2021/V21/I7/581

参考文献

[1] Chiari H. Ueber veränderungen des kleinhirns infolge von hydrocephalie des grosshirns 1[J]. Dtsch Med Wochenschr, 1891, 17:1172-1175.
[2] Fri? R, Eide PK. Chiari type 1-a malformation or a syndrome:a critical review[J]. Acta Neurochir (Wien), 2020, 162:1513-1525.
[3] McClugage SG, Oakes WJ. The chiari Ⅰ malformation[J]. J Neurosurg Pediatr, 2019, 24:217-226.
[4] Heiss JD, Jarvis K, Smith RK, Eskioglu E, Gierthmuehlen M, Patronas NJ, Butman JA, Argersinger DP, Lonser RR, Oldfield EH. Origin of syrinx fluid in syringomyelia:a physiological study[J]. Neurosurgery, 2019, 84:457-468.
[5] Dlouhy BJ, Dawson JD, Menezes AH. Intradural pathology and pathophysiology associated with Chiari Ⅰ malformation in children and adults with and without syringomyelia[J]. J Neurosurg Pediatr, 2017, 20:526-541.
[6] Chu W, Chen X, Xue X, He G, Liu J, Zhang H, Feng H, Lin J. Treatment of symptomatic Chiari Ⅰ malformation by "all-factors-surgery":a report of 194 cases[J]. Eur Spine J, 2021.[Epub ahead of print]
[7] Alexander H, Tsering D, Myseros JS, Magge SN, Oluigbo C, Sanchez CE, Keating RF. Management of Chiari Ⅰ malformations:a paradigm in evolution[J]. Childs Nerv Syst, 2019, 35:1809-1826.
[8] Wang K, Wu H, Fengzeng J, Zeng G. Opinion for different centers:surgical experience with Chiari malformation type Ⅰ in children at Xuanwu Hospital, China[J]. Childs Nerv Syst, 2019, 35:1915-1919.
[9] Shen J, Shen J, Huang K, Wu Y, Pan J, Zhan R. Syringobulbia in patients with Chiari malformation type Ⅰ:a systematic review[J]. Biomed Res Int, 2019:4829102.
[10] Bao C, Yang F, Liu L, Wang B, Li D, Gu Y, Zhang S, Chen L. Surgical treatment of Chiari Ⅰ malformation complicated with syringomyelia[J]. Exp Ther Med, 2013, 5:333-337.
[11] Grangeon L, Puy L, Gilard V, Hebant B, Langlois O, Derrey S, Gerardin E, Maltete D, Guegan-Massardier E, Magne N. Predictive factors of headache resolution after Chiari type 1 malformation surgery[J]. World Neurosurg, 2018, 110:e60-66.
[12] Olszewski AM, Proctor MR. Headache, Chiari Ⅰ malformation and foramen magnum decompression[J]. Curr Opin Pediatr, 2018, 30:786-790.
[13] Barkovich AJ, Wippold FJ, Sherman JL, Citrin CM. Significance of cerebellar tonsillar position on MR[J]. AJNR Am J Neuroradiol, 1986, 7:795-799.
[14] Guan J, Yuan C, Zhang C, Ma L, Yao Q, Cheng L, Liu Z, Wang K, Duan W, Wang X, Wang Z, Wu H, Chen Z, Jian F. A novel classification and its clinical significance in Chiari Ⅰ malformation with syringomyelia based on high-resolution MRI[J]. Eur Spine J, 2021[.Epub ahead of print]
[15] Vaquero J, Martínez R, Arias A. Syringomyelia-Chiari complex:magnetic resonance imaging and clinical evaluation of surgical treatment[J]. J Neurosurg, 1990, 73:64-68.
[16] Tator CH, Meguro K, Rowed DW. Favorable results with syringosubarachnoid shunts for treatment of syringomyelia[J]. J Neurosurg, 1982, 56:517-523.
[17] Aliaga L, Hekman KE, Yassari R, Straus D, Luther G, Chen J, Sampat A, Frim D. A novel scoring system for assessing Chiari malformation type Ⅰ treatment outcomes[J]. Neurosurgery, 2012, 70:656-664.
[18] De Vlieger J, Dejaegher J, Van Calenbergh F. Posterior fossa decompression for Chiari malformation type Ⅰ:clinical and radiological presentation, outcome and complications in a retrospective series of 105 procedures[J]. Acta Neurol Belg, 2019, 119:245-252.
[19] Jia C, Li H, Wu J, Gao K, Zhao CB, Li M, Sun X, Yang B. Comparison decompression by duraplasty or cerebellar tonsillectomy for Chiari malformation-Ⅰ complicated with syringomyelia[J]. Clin Neurol Neurosurg, 2019, 176:1-7.
[20] Chai Z, Xue X, Fan H, Sun L, Cai H, Ma Y, Ma C, Zhou R. Efficacy of posterior fossa decompression with duraplasty for patients with Chiari malformation type Ⅰ:a systematic review and meta-analysis[J]. World Neurosurg, 2018, 113:357-365.
[21] Giammattei L, Borsotti F, Parker F, Messerer M. Chiari Ⅰ malformation:surgical technique, indications and limits[J]. Acta Neurochir (Wien), 2018, 160:213-217.
[22] Menezes AH, Greenlee JDW, Dlouhy BJ. Syringobulbia in pediatric patients with Chiari malformation type Ⅰ[J]. J Neurosurg Pediatr, 2018, 22:52-60.
[23] Xu H, Chu L, He R, Ge C, Lei T. Posterior fossa decompression with and without duraplasty for the treatment of Chiari malformation type Ⅰ-a systematic review and meta-analysis[J]. Neurosurg Rev, 2017, 40:213-221.
[24] Raza-Knight S, Mankad K, Prabhakar P, Thompson D. Headache outcomes in children undergoing foramen magnum decompression for Chiari Ⅰ malformation[J]. Arch Dis Child, 2017, 102:238-243.
[25] Abu-Arafeh I, Campbell E. Headache, Chiari malformation type 1 and treatment options[J]. Arch Dis Child, 2017, 102:210-211.
[26] Olesen J. International classification of headache disorders[J]. Lancet Neurol, 2018, 17:396-397.
[27] Thakar S, Sivaraju L, Jacob KS, Arun AA, Aryan S, Mohan D, Sai Kiran NA, Hegde AS. A points-based algorithm for prognosticating clinical outcome of Chiari malformation type Ⅰ with syringomyelia:results from a predictive model analysis of 82 surgically managed adult patients[J]. J Neurosurg Spine, 2018, 28:23-32.
[28] Nagoshi N, Iwanami A, Toyama Y, Nakamura M. Factors contributing to improvement of syringomyelia after foramen magnum decompression for Chiari type Ⅰ malformation[J]. J Orthop Sci, 2014, 19:418-423.

选择文件类型/文献管理软件名称

选择包含的内容

2 Chiari畸形1型合并脊髓空洞症手术预后分析

Prognostic analysis of surgical treatment of Chiari malformation type 1 complicated with syringomyelia

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	倪洋, 张昉, 张勇, 林劲芝. 基于影像组学的神经血管压迫与原发性三叉神经痛关系探讨[J]. 中国现代神经疾病杂志, 2024, 24(8): 668-673.
[2]	程矫, 甄勇, 宋炳伟, 刘健伟, 耿平. 高级别动脉瘤性蛛网膜下腔出血伴脑内血肿临床预后分析[J]. 中国现代神经疾病杂志, 2024, 24(7): 567-572.
[3]	中华医学会神经外科学分会, 中国神经外科重症管理协作组. 舒巴坦治疗神经外科重症患者鲍曼不动杆菌感染中国专家共识[J]. 中国现代神经疾病杂志, 2024, 24(6): 407-424.
[4]	谭波, 张钺, 杨佳强, 刘永东, 焦阳, 王贝. 创伤性脑疝患者去骨瓣减压术后脑积水危险因素分析以及贝叶斯网络模型构建[J]. 中国现代神经疾病杂志, 2024, 24(6): 442-449.
[5]	赵浩, 曲鑫, 王宁, 尚峰, 徐跃峤, 齐猛. 脑积水腰大池-腹腔分流术预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(6): 450-454.
[6]	张笑, 银锐, 李鹏涛, 常健博, 孙思帅, 魏俊吉. 神经内镜硬膜下血肿清除术与钻孔引流术联合尿激酶治疗分隔型慢性硬膜下血肿疗效对比[J]. 中国现代神经疾病杂志, 2024, 24(6): 455-460.
[7]	韩若东, 张亚飞, 颜秀侠, 李博文, 钱贝丽. 新型简易徒手锥颅血肿引流术治疗高血压脑出血疗效分析[J]. 中国现代神经疾病杂志, 2024, 24(6): 461-470.
[8]	米晓璐, 齐洪娜, 王维展, 孙少杰, 武艳品. 脂蛋白相关磷脂酶A2联合系统性炎症反应指数对急性一氧化碳中毒迟发性脑病的预测价值[J]. 中国现代神经疾病杂志, 2024, 24(6): 483-490.
[9]	叶睿曦, 蔡林君, 孔雪莹, 李劲梅, 周东, 洪桢. 抗N-甲基-D-天冬氨酸受体脑炎急性期严重程度及短期预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(5): 331-339.
[10]	徐坤榕, 王晓娟, 张弥兰, 薛红飞, 徐佳佳, 李玮. 单纯疱疹病毒1型脑炎临床特点及预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(4): 224-229.
[11]	熊冰婕, 曹飘, 张骏, 张海清. 隐球菌性脑膜炎预后不良危险因素分析及列线图预测模型构建[J]. 中国现代神经疾病杂志, 2024, 24(4): 230-237.
[12]	王建宇, 白云鹏. 主动脉夹层围手术期神经系统并发症的危险因素与治疗策略[J]. 中国现代神经疾病杂志, 2024, 24(2): 97-101.
[13]	王培健, 魏铭. 心脑血管疾病的预防与管理策略[J]. 中国现代神经疾病杂志, 2024, 24(2): 106-112.
[14]	佟小光, 施铭岗. 应重视心脑血管疾病的外科干预[J]. 中国现代神经疾病杂志, 2024, 24(1): 1-4.
[15]	施铭岗, 佟小光. 心脑血管疾病的“脑心同治”[J]. 中国现代神经疾病杂志, 2024, 24(1): 17-21.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 Chiari畸形1型合并脊髓空洞症手术预后分析

Prognostic analysis of surgical treatment of Chiari malformation type 1 complicated with syringomyelia

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价